Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets
F Ahmad, T Murata, K Shimizu, E Degerman… - Oral …, 2015 - Wiley Online Library
By catalyzing hydrolysis of cyclic adenosine monophosphate (cAMP) and cyclic guanosine
monophosphate (cGMP), cyclic nucleotide phosphodiesterases are critical regulators of their …
monophosphate (cGMP), cyclic nucleotide phosphodiesterases are critical regulators of their …
Cyclic nucleotide phosphodiesterases (PDEs): diverse regulators of cyclic nucleotide signals and inviting molecular targets for novel therapeutic agents
VC Manganiello, E Degerman - Thrombosis and haemostasis, 1999 - thieme-connect.com
Cyclic adenosine 3'5'-monophosphate (cAMP) and cyclic guanosine 3'5'-monophoshpate
(cGMP) are critical intracellular second-messengers involved in the transduction of a wide …
(cGMP) are critical intracellular second-messengers involved in the transduction of a wide …
Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents
C Lugnier - Pharmacology & therapeutics, 2006 - Elsevier
Cyclic nucleotide phosphodiesterases (PDEs), which are ubiquitously distributed in
mammalian tissues, play a major role in cell signaling by hydrolyzing cAMP and cGMP. Due …
mammalian tissues, play a major role in cell signaling by hydrolyzing cAMP and cGMP. Due …
Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use
AT Bender, JA Beavo - Pharmacological reviews, 2006 - ASPET
Cyclic nucleotide phosphodiesterases (PDEs) are enzymes that regulate the cellular levels
of the second messengers, cAMP and cGMP, by controlling their rates of degradation. There …
of the second messengers, cAMP and cGMP, by controlling their rates of degradation. There …
Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions
SH Francis, MA Blount, JD Corbin - Physiological reviews, 2011 - journals.physiology.org
The superfamily of cyclic nucleotide (cN) phosphodiesterases (PDEs) is comprised of 11
families of enzymes. PDEs break down cAMP and/or cGMP and are major determinants of …
families of enzymes. PDEs break down cAMP and/or cGMP and are major determinants of …
Role of phosphodiesterase 1 in the pathophysiology of diseases and potential therapeutic opportunities
Cyclic nucleotide phosphodiesterases (PDEs) are superfamily of enzymes that regulate the
spatial and temporal relationship of second messenger signaling in the cellular system …
spatial and temporal relationship of second messenger signaling in the cellular system …
Advances in targeting cyclic nucleotide phosphodiesterases
DH Maurice, H Ke, F Ahmad, Y Wang… - Nature reviews Drug …, 2014 - nature.com
Cyclic nucleotide phosphodiesterases (PDEs) catalyse the hydrolysis of cyclic AMP and
cyclic GMP, thereby regulating the intracellular concentrations of these cyclic nucleotides …
cyclic GMP, thereby regulating the intracellular concentrations of these cyclic nucleotides …
Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives …
T Keravis, C Lugnier - British journal of pharmacology, 2012 - Wiley Online Library
Cyclic nucleotide phosphodiesterases (PDEs) that specifically inactivate the intracellular
messengers cAMP and cGMP in a compartmentalized manner represent an important …
messengers cAMP and cGMP in a compartmentalized manner represent an important …
[图书][B] Cyclic nucleotide phosphodiesterases in health and disease
J Beavo, SH Francis, MD Houslay - 2007 - api.taylorfrancis.com
The establishment of a Gordon Research Conference devoted to cyclic nucleotide
phosphodiesterases has had an enormous impact on the field by facilitating collaborations …
phosphodiesterases has had an enormous impact on the field by facilitating collaborations …
Cyclic nucleotide phosphodiesterases: gene complexity, regulation by phosphorylation, and physiological implications
F Burns, AZ Zhao, JA Beavo - Advances in Pharmacology, 1996 - Elsevier
Publisher Summary The intracellular levels of cyclic nucleotides are regulated through
synthesis by adenylyl and guanylyl cyclases and also degradation by phosphodiesterases …
synthesis by adenylyl and guanylyl cyclases and also degradation by phosphodiesterases …
相关搜索
- therapeutic targets signaling modulators
- nucleotide signals molecular targets
- nucleotide phosphodiesterase pde inhibitors
- nucleotide phosphodiesterases molecular regulation
- nucleotide phosphodiesterase various diseases
- nucleotide phosphodiesterases clinical use
- nucleotide phosphodiesterases gene complexity
- nucleotide phosphodiesterases physiological implications
- nucleotide phosphodiesterase signalling network
- nucleotide phosphodiesterases molecular targets
- nucleotide phosphodiesterases regulation by phosphorylation
- nucleotide phosphodiesterases health and disease